ArticleAmerican journal of translational research2022

Differential effects of poly(ADP ribose) polymerase inhibitor-based metronomic therapy on programmed death-ligand 1 and matrix-associated factors in human myeloid cells.

Salome V Ibba et al.PubMed ↗Full text ↗

No numbers read from the abstract.